Molteni Farmaceutici S.p.A is a leading company in the market of opioid drugs, always engaged in the research and implementation of therapeutic solutions for the treatment of pain and addictions in defense of the quality of life and the right to adequate therapy of patients.
eCRF development, data management and statistical consultancy activities related to clinical trials promoted by Molteni Farmaceutici
In conformity with Article 26 of the Legislative Decree of August 5, 2022 and the Guidelines of the Italian Ministry of Health March 28, 2013 and December 20, 2017, the information in this section of the website is intended only for healthcare professionals. By selecting Continue, you declare that you are a healthcare professional, allowing you to continue to access the area dedicated to the ARIA medical device.
In conformity with Article 26 of the Legislative Decree of August 5, 2022 and the Guidelines of the Italian Ministry of Health March 28, 2013 and December 20, 2017, the information in this section of the website is intended only for healthcare professionals. By selecting Continue, you declare that you are a healthcare professional, allowing you to continue to access the area dedicated to the ARIA medical device.
